More articles from Conference Proceeding

You have access
Introduction to Workshop: Adventitious Viruses in Biologics—Detection and Mitigation Strategies
Arifa S. Khan, Patricia Hughes and Michael Wiebe

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 544-546; DOI: https://doi.org/10.5731/pdajpst.2011.00817
You have access
PDA Cell Substrate Task Force: Emerging Technologies for Virus Detection Technical Document—A Progress Report
Kathryn King and Michael Wiebe

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 693; DOI: https://doi.org/10.5731/pdajpst.2011.00844
You have access
Theory and Practice of Conventional Adventitious Virus Testing
Jens-Peter Gregersen

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 634-644; DOI: https://doi.org/10.5731/pdajpst.2011.00832
You have access
Detection of Latent Retroviruses in Vaccine-related Cell Substrates: Investigation of RT Activity Produced by Chemical Induction of Vero Cells
Hailun Ma and Arifa S. Khan

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 685-689; DOI: https://doi.org/10.5731/pdajpst.2011.00843
You have access
Case Study of Apparent Virus Contamination in Biopharmaceutical Product at Centocor
Linda C. Hendricks and Dominick A. Vacante

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 612-613; DOI: https://doi.org/10.5731/pdajpst.2011.00825
You have access
Regulatory Approaches for Control of Viral Contamination of Vaccines
Shasta McClenahan, Christine Uhlenhaut and Philip R. Krause

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 557-562; DOI: https://doi.org/10.5731/pdajpst.2011.00819
You have access
Practicing Safe Cell Culture: Applied Process Designs for Minimizing Virus Contamination Risk
Robert D. Kiss

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 715-729; DOI: https://doi.org/10.5731/pdajpst.2011.00852
You have access
Evolution of Approaches to Viral Safety Issues for Biological Products
Anthony S. Lubiniecki

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 547-556; DOI: https://doi.org/10.5731/pdajpst.2011.00818
You have access
FDA Post-Approval Expectations for Adventitious Virus Contamination Prevention
Richard L. Friedman

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 698-712; DOI: https://doi.org/10.5731/pdajpst.2011.00846
You have access
TSE Case Studies Associated with Japanese and Other Regulatory Authorities—Talk Transcript
Barbara J. Potts

PDA Journal of Pharmaceutical Science and Technology September 2010, 64 (5) 442-444;

Main menu

User menu

Search

More articles from Conference Proceeding

Pages

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.